Tag Archives: PReP

Microbicides and other ARV-based prevention: Biomedical answers meet challenges on the ground

By on .

Does adherence to using a product intended to prevent HIV acquisition depend on willingness, or ability to use the product? What are the factors — whether thoughts, beliefs, structural obstacles or social barriers — influencing both? The challenges that women have faced since the recognition of HIV in protecting themselves from getting the virus by […]

WHO releases key population HIV guidelines, with new recommendations for PrEP and opioid overdose management, updated evidence for prison responses, call for law, policy reviews

By on .

Men who have sex with men, incarcerated people, people who inject drugs, people involved in sex work, and transgender people are focus of first consolidated guidelines addressing issues common to all, as well as specific needs They are the people on whom the global AIDS pandemic has had the highest impact, and yet who have […]

HIV transmission risks: Review updates CDC estimates, adds impact of treatment, condom use

By on .

Authors of a comprehensive review of literature reporting data on per-act HIV transmission risks have updated the last estimates produced by the U.S. Centers for Disease Control and Prevention in 2005, and in the process have highlighted the importance of treatment and prevention reaching those at greatest risk. The CDC’s estimates “relied heavily on estimates […]

Uganda law concerns at home and abroad, CDC PrEP guidelines endorsed, getting ready for World AIDS Vaccine Day . . . We’re reading about what’s next

By on .

Ambassador Deborah Birx, on the Passage of the HIV Prevention and Control Act by the Ugandan Parliament -  With more than three decades of experiences at home and abroad offering lessons, Global AIDS Coordinator Ambassador Deborah Birx responds to the Uganda Parliament’s new HIV and AIDS Prevention and Control Act, which criminalizes HIV transmission, mandates […]

Making AIDS history, amfAR counts down to a cure at Capitol Hill briefing

By on .

Ambassador Deborah Birx,  Anthony Fauci, Michel Sidibe, Kenneth Cole, Miss Universe, Rep. Nancy Pelosi, Sen. Tom Harkin, and World Bank President Jim Kim among participants in event to “Make AIDS History.” It already sounds like history now, before testing, before treatment, before activism, science, money and policy introduced hope into the time when an AIDS […]

Injectable ARVs and PReP, viral load testing developments, questions on Global Funds in Nigeria and Uganda, we’re reading updates and more . . .

By on .

AVAC’s latest PxWire – News at March’s Conference on Retroviruses and Opportunistic Infections that monthly injections of antiretroviral drugs offered monkeys protection against vaginal and rectal HIV exposure paved the way for investigating if the approach would work for people too, and raised expectations that long-acting PReP, or pre-exposure prevention of HIV is possible, AVAC […]

CROI 2014: PrEP pilots to launch in resource-limited settings

By on .

BOSTON, MASS – Dr. Nelly Mugo from the Kenya Medical Research Institute in Nairobi was able to summarize the use of antiretroviral drugs to prevent HIV acquisition — pre-exposure prophylaxis, or PrEP — in resource limited settings quickly this week. That is because, after a series of clinical trials demonstrating the effectiveness of that prevention […]

AVAC: HIV vaccine, microbicides, PrEP trial results say reality must guide research

By on .

For all the graphics illustrating results of HIV prevention trials in recent years, the Venn diagram on the cover of Research & Reality, the report released by AVAC today, may be the one that depicts the sum of their findings. Which is really saying something, when one considers the up-and-down nature of prevention research results […]

Report shows U.S. HIV research investment, progress; projects lasting impact from cuts

By on .

With the United States funding 70 percent of the world’s research and development of biomedical answers to HIV prevention, progress that has yielded the potential for immediate advances against the global epidemic is in danger of stalling, with lasting consequences, according to a report released at the International AIDS Society conference in Kuala Lumpur this […]

With study of injecting drug users, preventive HIV medicine demonstrates protective value to all at high risk

By on .

CDC releases updated Guidance for Pre-Exposure Prophylaxis for the Prevention of HIV Infection: PrEP for Injecting Drug Users, while questions on real-world impact remain With a five-year study in Bangkok showing that daily doses of antiretroviral medicine reduced risks of HIV infection among people who inject drugs by at least half, and more with the […]